The estimated Net Worth of Peter P. Pfreundschuh is at least 732 千$ dollars as of 21 February 2024. Mr Pfreundschuh owns over 3,764 units of Frequency Therapeutics Inc stock worth over 52,701$ and over the last 11 years he sold FREQ stock worth over 144,666$. In addition, he makes 535,000$ as Chief Financial Officer at Frequency Therapeutics Inc.
Mr has made over 14 trades of the Frequency Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,764 units of FREQ stock worth 28,079$ on 21 February 2024.
The largest trade he's ever made was exercising 15,000 units of Frequency Therapeutics Inc stock on 14 February 2022 worth over 4,500$. On average, Mr trades about 1,728 units every 53 days since 2013. As of 21 February 2024 he still owns at least 175,669 units of Frequency Therapeutics Inc stock.
You can see the complete history of Mr Pfreundschuh stock trades at the bottom of the page.
Peter P. Pfreundschuh is the Chief Financial Officer at Frequency Therapeutics Inc.
As the Chief Financial Officer of Frequency Therapeutics Inc, the total compensation of Mr Pfreundschuh at Frequency Therapeutics Inc is 535,000$. There are 5 executives at Frequency Therapeutics Inc getting paid more, with David Lucchino having the highest compensation of 7,364,600$.
Mr Pfreundschuh is 52, he's been the Chief Financial Officer of Frequency Therapeutics Inc since . There are 8 older and 8 younger executives at Frequency Therapeutics Inc. The oldest executive at Frequency Therapeutics Inc is Timothy Barberich, 72, who is the Independent Director.
Peter's mailing address filed with the SEC is C/O Y-MABS THERAPEUTICS, INC., 230 PARK AVENUE, SUITE 3350, NEW YORK, NY, 10169.
Over the last 5 years, insiders at Frequency Therapeutics Inc have traded over 11,017,122$ worth of Frequency Therapeutics Inc stock and bought 369,233 units worth 5,339,982$ . The most active insiders traders include Joel S Marcus、Robert Langer、Marc A Cohen. On average, Frequency Therapeutics Inc executives and independent directors trade stock every 11 days with the average trade being worth of 3,858$. The most recent stock trade was executed by Richard J. Mitrano on 18 August 2023, trading 464 units of FREQ stock currently worth 269$.
frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.
Frequency Therapeutics Inc executives and other stock owners filed with the SEC include: